As of November 10, 2026, 22 biotech companies in Northern New Jersey have filed a new SEC Form D on record, reporting $1.18B sold. 1 filed in the last 90 days, against 3 in the 90 days before. The biggest raise on record here is LISATA THERAPEUTICS, INC., at $351.90M (SEC Form D, October 2, 2026).
1 biotech companies in Northern New Jersey filed in the last 90 days, against 3 in the 90 days before. The biggest raise on record here is LISATA THERAPEUTICS, INC. at $351.90M.
Companies raising per week
The last 90 days
| Based | People named | |||
|---|---|---|---|---|
| LISATA THERAPEUTICS, INC. first filing | $351.90M | 2026-10-02 | Basking Ridge, NJ | David Mazzo, James Nisco +7 |
First-time filers, last 90 days
LISATA THERAPEUTICS, INC..
Everything on record
| Based | People named | |||
|---|---|---|---|---|
| LISATA THERAPEUTICS, INC. first filing | $351.90M | 2026-10-02 | Basking Ridge, NJ | David Mazzo, James Nisco +7 |
| Rhodenergy An Environmental Co Corp first filing | $250M | 2026-01-15 | Princeton, NJ | Irfan Jameel |
| Legend Biotech Corp first filing | $200M | 2023-04-28 | Somerset, NJ | Ying Huang, Ph.D., Lori Macomber +9 |
| Aadi Bioscience, Inc. | $100M | 2025-03-18 | Morristown, NJ | Dave Lennon, Scott Giacobello +11 |
| VYNE Therapeutics Inc. | $88.15M | 2023-11-16 | Bridgewater, NJ | David Domzalski, Tyler Zeronda +7 |
| Character Biosciences, Inc. first filing | $48.17M | 2025-05-12 | Jersey City, NJ | Cheng Zhang, Nick Olsen +2 |
| AMICUS THERAPEUTICS, INC. first filing | $30M | 2023-10-16 | Princeton, NJ | Bradley Campbell, Simon Harford +12 |
| Cellectar Biosciences, Inc. first filing | $24.50M | 2023-09-22 | Florham Park, NJ | James Caruso, Chad Kolean +8 |
| Grace Therapeutics, Inc. | $15M | 2025-02-25 | Princeton, NJ | Prashant Kohli, Vimal Kavuru +7 |
| Claris Biotherapeutics, Inc. | $10M | 2024-01-08 | Jersey City, NJ | Clarke Atwell, Reza Dana +5 |
| Character Biosciences, Inc. | $8.86M | 2025-09-17 | Jersey City, NJ | Cheng Zhang, Nick Olsen +6 |
| Celularity Inc first filing | $6.81M | 2025-08-05 | Florham Park, NJ | Robert Hariri, John Haines +6 |
| Sonnet BioTherapeutics Holdings, Inc. | $3.92M | 2024-12-23 | Princeton, NJ | Pankaj Mohan, Jay Cross +8 |
| Claris Biotherapeutics, Inc. | $3.30M | 2025-03-07 | Jersey City, NJ | Clarke Atwell, Reza Dana +5 |
| Hepion Pharmaceuticals, Inc. | $3.06M | 2026-08-05 | Red Bank, NJ | Gary Stetz, Vincent LoPriore +5 |
| Tharimmune, Inc. | $2.50M | 2025-07-07 | Red Bank, NJ | Sireesh Appajosyula, Vincent LoPriore +4 |
| Claris Biotherapeutics, Inc. | $2.30M | 2025-09-22 | Jersey City, NJ | Clarke Atwell, Reza Dana +5 |
| Sonnet BioTherapeutics Holdings, Inc. first filing | $2.25M | 2023-07-17 | Princeton, NJ | Pankaj Mohan, Jay Cross +7 |
| Starton Therapeutics Inc. | $2.13M | 2024-10-22 | Paramus, NJ | Pedro Lichtinger Waisman, Fotios Plakogiannis +9 |
| Tharimmune, Inc. first filing | $2.08M | 2024-06-28 | Bridgewater, NJ | Randy Milby, Thomas Hess +4 |
| Tharimmune, Inc. | $2.02M | 2024-12-17 | Bridgewater, NJ | Randy Milby, Thomas Hess +5 |
| Celularity Inc | $2M | 2025-11-03 | Florham Park, NJ | Robert Hariri, John Haines +6 |
| Celularity Inc first filing | $2M | 2025-08-05 | Florham Park, NJ | Robert Hariri, John Haines +6 |
| Optimeos Life Sciences, Inc. first filing | $1.88M | 2023-07-07 | Princeton, NJ | Shahram Hejazi, PhD, Robert Prud'homme, PhD +1 |
| Canton Strategic Holdings, Inc. | $1.74M | 2026-04-15 | Red Bank, NJ | Mark Wendland, Jacob Asbury +8 |
| Starton Therapeutics Inc. | $1.44M | 2023-04-13 | Paramus, NJ | Pedro Lichtinger Waisman, Fotios Plakogiannis +9 |
| Bullseye Biodevices, Inc. first filing | $1.30M | 2026-08-10 | Hoboken, NJ | Jinho Kim, Mohammad Mir |
| Canton Strategic Holdings, Inc. | $1.23M | 2026-04-15 | Red Bank, NJ | Mark Wendland, Jacob Asbury +8 |
| Celularity Inc first filing | $1.03M | 2025-08-05 | Florham Park, NJ | Robert Hariri, John Haines +6 |
| Starton Therapeutics Inc. first filing | $1.02M | 2023-01-25 | Paramus, NJ | Pedro Lichtinger Waisman, Cidnee Vaykovich +9 |
| Synchrony Medical Inc. first filing | $1M | 2025-09-12 | Jersey City, NJ | Anat Shani, Eileen Ke +1 |
| Optimeos Life Sciences, Inc. | $1M | 2026-06-03 | Princeton, NJ | Shahram Hejazi, Robert Prud'homme +2 |
| Starton Therapeutics Inc. | $971K | 2023-10-13 | Paramus, NJ | Pedro Lichtinger Waisman, Fotios Plakogiannis +9 |
| Hepion Pharmaceuticals, Inc. | $700K | 2026-04-22 | Red Bank, NJ | Gary Stetz, Vincent LoPriore +4 |
| Origin Life Sciences, Inc. first filing | $500K | 2023-06-01 | Princeton, NJ | Michael Preston, David Dantzker +4 |
| Thoclor US, Inc. first filing | $225K | 2026-02-12 | Florham Park, NJ | Tom Hadley, Hennie Roos +3 |
| Santiste Medical Inc. first filing | $89K | 2023-03-24 | Princeton, NJ | Mark Eisenach, Walter Greenblatt |
| Origin Life Sciences, Inc. | $51K | 2023-10-17 | Princeton, NJ | Michael Preston, David Dantzker +4 |
| Certara, Inc. first filing | — | 2024-03-27 | Princeton, NJ | William Feehery, John Gallagher III +13 |
Reach the founders of these 22 Biotech in Northern New Jersey companies, each named in its filing, and keep them in one pipeline.
Start free in MentionFoxTurn your raise into a launch page, press kit and share cards, built from your own work.
Get your launch kitOther sectors in Northern New Jersey
Health care AI and software Pharmaceuticals Energy and climate Retail and restaurants
Biotech in other metros
New York Minneapolis-St. Paul Baltimore Raleigh-Durham Austin Seattle San Diego Houston San Francisco Bay Area Phoenix Detroit Boston Los Angeles Dallas-Fort Worth St. Louis Miami Denver and Boulder Salt Lake City Atlanta Philadelphia Washington, DC Portland Chicago Orlando and Tampa Pittsburgh Las Vegas
How this list is built
Every company here filed a Form D with the SEC from this sector and metro. A Form D is the notice a company files when it sells shares or other securities without a public offering, so it catches seed rounds, small rounds and rounds that were never announced, alongside the large ones that make the news. Only new offerings by operating companies count: amendments, pooled investment funds, real estate vehicles and special purpose vehicles are left out, so each row is a company raising money for itself.
The amount shown is the total the filing reports as sold so far. Some filings report nothing sold yet; those rows show a dash and add nothing to the totals. "First filing" marks a company whose first Form D on record this is. Each company links to our page for the filing, or to the SEC's own copy, and the list can be copied as CSV for a spreadsheet.
Cite this page
https://mentionfox.com/funding/biotech/new-jersey